-Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine for Phase 1 Clinical Trial of RP-L401

  • Jonathan Schwartz,

Press/Media

Period16 Nov 2020

Media coverage

1

Media coverage

  • Title-Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine for Phase 1 Clinical Trial of RP-L401
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date16/11/20
    PersonsJonathan Schwartz,
View all 1
View less